Trials
Search / Trial NCT06421025

Blood Viscosity in Polycythemia Patients

Launched by HOSPICES CIVILS DE LYON · May 15, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Not yet recruiting

Keywords

Polycythemia Viscosity Thromboelastometry Thrombosis

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • 18 years of age or older
  • • Followed for a diagnosis or suspicion of polycythemia (hematocrit greater than or equal to 49% in men and 48% in women), whatever the suspected etiology.
  • • Patient affiliated to a social security scheme or similar
  • Exclusion Criteria:
  • • Patient having undergone therapeutic bloodletting within 3 months prior to inclusion, or having initiated cytoreductive therapy prior to inclusion.
  • • Any disease or condition other than polycythemia, chronic or not, likely to induce a change in blood viscosity (at the investigator's discretion)
  • • Patient participating in another interventional research protocol that may interfere with the present protocol (at the investigator's discretion).
  • • Patient under guardianship, curatorship or safeguard of justice
  • • Person under psychiatric care
  • • Patient under legal protection.

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Pierre Bénite, Lyon, France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0